PI3K/AKT/mTOR通路
蛋白激酶B
癌症研究
基因敲除
肿瘤进展
生物
细胞生长
化学
作者
Xiaopei Hao,Yao Zhang,Yiwei Lu,Guoyong Han,Dawei Rong,Guoqiang Sun,Guangshun Sun,Weiwei Tang,Jindao Wu,Xue-Hao Wang
出处
期刊:iScience
[Cell Press]
日期:2021-11-19
卷期号:24 (11): 103223-103223
标识
DOI:10.1016/j.isci.2021.103223
摘要
Serine/threonine kinase 39 (STK39) is overexpressed in various tumor tissues and plays an essential role in tumor progression. In this study, we investigated the clinical value, as well as the potential functions and mechanisms of STK39 in cholangiocarcinoma (CCA). The results showed that STK39 was overexpressed in CCA and negatively associated with the prognosis of patients with CCA. Functionally, STK39 knockdown suppressed cell proliferation, migration, and invasion, while STK39 overexpression facilitated tumor aggressiveness. The tumor-promoting effects of STK39 in CCA were also validated by in vivo experiments. Mechanistically, RNA-seq analysis identified that STK39 enhanced the progression of CCA by activating PI3K/AKT signaling pathway. Furthermore, overexpression of STK39 could induce gemcitabine resistance in CCA cells. Moreover, the increased expression of STK39 may be mediated by the dysregulation of miR-26a-5p. In summary, STK39 could be served as a valuable prognostic candidate and a potential therapeutic target of CCA.
科研通智能强力驱动
Strongly Powered by AbleSci AI